S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Bank of East Asia, Limited stock logo
BKEAY
Bank of East Asia
$1.17
$1.20
$1.09
$1.52
$3.09B0.26949 shs58 shs
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$22.33
-7.9%
$24.22
$21.28
$27.15
$4.92B0.5186 shs204 shs
Orion Oyj stock logo
ORINY
Orion Oyj
$18.00
$19.69
$18.00
$24.40
$5.08B0.2352 shs19 shs
ROHM Co., Ltd. stock logo
ROHCY
ROHM
$14.06
+1.1%
$16.45
$13.87
$25.04
$5.46B1.1524,633 shs37,608 shs
Koninklijke Vopak stock logo
VOPKY
Koninklijke Vopak
$39.53
$36.86
$31.65
$39.99
N/A0.651,173 shs9 shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Bank of East Asia, Limited stock logo
BKEAY
Bank of East Asia
0.00%-0.85%-1.74%+2.66%-4.41%
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
-7.92%-7.92%-4.45%-8.95%+8.19%
Orion Oyj stock logo
ORINY
Orion Oyj
0.00%0.00%-5.26%-20.62%-29.15%
ROHM Co., Ltd. stock logo
ROHCY
ROHM
+1.08%-5.13%-15.48%-22.98%-28.77%
Koninklijke Vopak stock logo
VOPKY
Koninklijke Vopak
0.00%-1.15%+9.30%+21.10%+1.33%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Bank of East Asia, Limited stock logo
BKEAY
Bank of East Asia
N/AN/AN/AN/AN/AN/AN/AN/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Orion Oyj stock logo
ORINY
Orion Oyj
N/AN/AN/AN/AN/AN/AN/AN/A
ROHM Co., Ltd. stock logo
ROHCY
ROHM
N/AN/AN/AN/AN/AN/AN/AN/A
Koninklijke Vopak stock logo
VOPKY
Koninklijke Vopak
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Bank of East Asia, Limited stock logo
BKEAY
Bank of East Asia
N/AN/AN/AN/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
2.00
HoldN/AN/A
Orion Oyj stock logo
ORINY
Orion Oyj
2.00
HoldN/AN/A
ROHM Co., Ltd. stock logo
ROHCY
ROHM
3.00
BuyN/AN/A
Koninklijke Vopak stock logo
VOPKY
Koninklijke Vopak
3.00
BuyN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Bank of East Asia, Limited stock logo
BKEAY
Bank of East Asia
$5.56B0.56$0.23 per share5.16$5.22 per share0.22
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$2.88B1.71$3.06 per share7.29$10.03 per share2.23
Orion Oyj stock logo
ORINY
Orion Oyj
$1.29B3.95$1.48 per share12.15$3.39 per share5.31
ROHM Co., Ltd. stock logo
ROHCY
ROHM
$3.76B1.47$2.35 per share5.98N/A
Koninklijke Vopak stock logo
VOPKY
Koninklijke Vopak
$1.54BN/A$5.41 per share7.31N/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Bank of East Asia, Limited stock logo
BKEAY
Bank of East Asia
$525.87MN/A0.004.180.34N/AN/AN/AN/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$190MN/A0.0010.20N/AN/AN/AN/AN/A
Orion Oyj stock logo
ORINY
Orion Oyj
$234.62M$0.8421.4317.65N/A18.21%27.75%16.32%N/A
ROHM Co., Ltd. stock logo
ROHCY
ROHM
$594.78MN/A0.0023.83N/AN/AN/AN/AN/A
Koninklijke Vopak stock logo
VOPKY
Koninklijke Vopak
$493.20M$3.9310.0611.66N/A32.00%12.58%6.09%N/A

Latest VOPKY, ORINY, ROHCY, BKEAY, and HKMPF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/14/2024Q4 2023
Koninklijke Vopak stock logo
VOPKY
Koninklijke Vopak
$0.82$0.94+$0.12$1.14N/A$379.89 million
2/13/2024Q4 2023
Orion Oyj stock logo
ORINY
Orion Oyj
N/A$0.29+$0.29$0.29N/A$345.76 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Bank of East Asia, Limited stock logo
BKEAY
Bank of East Asia
$0.043.42%N/AN/AN/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$0.944.21%N/AN/AN/A
Orion Oyj stock logo
ORINY
Orion Oyj
$0.372.06%N/A44.05%N/A
ROHM Co., Ltd. stock logo
ROHCY
ROHM
$0.261.85%N/AN/AN/A
Koninklijke Vopak stock logo
VOPKY
Koninklijke Vopak
$1.172.96%N/A29.77%N/A

Latest VOPKY, ORINY, ROHCY, BKEAY, and HKMPF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/27/2024
Koninklijke Vopak stock logo
VOPKY
Koninklijke Vopak
$1.33474/26/20244/29/20245/17/2024
3/6/2024
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$0.473/20/20243/22/20245/3/2024
2/24/2024
The Bank of East Asia, Limited stock logo
BKEAY
Bank of East Asia
$0.02033/6/20243/7/20244/18/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Bank of East Asia, Limited stock logo
BKEAY
Bank of East Asia
0.01
0.91
0.91
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
0.47
1.57
0.90
Orion Oyj stock logo
ORINY
Orion Oyj
0.21
3.10
1.59
ROHM Co., Ltd. stock logo
ROHCY
ROHM
0.04
1.54
1.02
Koninklijke Vopak stock logo
VOPKY
Koninklijke Vopak
0.49
0.96
0.96

Ownership

Institutional Ownership

CompanyInstitutional Ownership
The Bank of East Asia, Limited stock logo
BKEAY
Bank of East Asia
N/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
N/A
Orion Oyj stock logo
ORINY
Orion Oyj
N/A
ROHM Co., Ltd. stock logo
ROHCY
ROHM
N/A
Koninklijke Vopak stock logo
VOPKY
Koninklijke Vopak
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
The Bank of East Asia, Limited stock logo
BKEAY
Bank of East Asia
8,0002.64 billionN/ANot Optionable
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
8,800220.23 millionN/ANot Optionable
Orion Oyj stock logo
ORINY
Orion Oyj
3,527282.27 millionN/ANot Optionable
ROHM Co., Ltd. stock logo
ROHCY
ROHM
23,754392.57 millionN/ANot Optionable
Koninklijke Vopak stock logo
VOPKY
Koninklijke Vopak
5,505N/AN/ANot Optionable

VOPKY, ORINY, ROHCY, BKEAY, and HKMPF Headlines

SourceHeadline
Koninklijke Vopak N.V.s (AMS:VPK) Intrinsic Value Is Potentially 64% Above Its Share PriceKoninklijke Vopak N.V.'s (AMS:VPK) Intrinsic Value Is Potentially 64% Above Its Share Price
finance.yahoo.com - April 10 at 8:09 AM
Koninklijke Vopak (OTCMKTS:VOPKY) Raises Dividend to $1.33 Per ShareKoninklijke Vopak (OTCMKTS:VOPKY) Raises Dividend to $1.33 Per Share
marketbeat.com - March 27 at 6:31 PM
Vopak, Air Liquide to jointly develop Singapore ammonia and hydrogen infrastructureVopak, Air Liquide to jointly develop Singapore ammonia and hydrogen infrastructure
reuters.com - March 11 at 12:43 AM
Vopak: Trading At A 10% Free Cash Flow Yield After A Surprisingly Strong 2023Vopak: Trading At A 10% Free Cash Flow Yield After A Surprisingly Strong 2023
seekingalpha.com - February 25 at 1:25 PM
Koninklijke Vopak NV (VPK5.DU)Koninklijke Vopak NV (VPK5.DU)
nz.finance.yahoo.com - February 22 at 10:27 PM
Koninklijke Vopak N.V. (VPK5.F)Koninklijke Vopak N.V. (VPK5.F)
au.finance.yahoo.com - February 22 at 10:26 PM
Koninklijke Vopak Full Year 2023 Earnings: EPS Misses ExpectationsKoninklijke Vopak Full Year 2023 Earnings: EPS Misses Expectations
finance.yahoo.com - February 17 at 9:07 AM
Vopak announces share buyback program to return up to EUR 300 million to shareholdersVopak announces share buyback program to return up to EUR 300 million to shareholders
finance.yahoo.com - February 14 at 7:01 AM
Vopak reports FY 2023 and Q4 2023 financial resultsVopak reports FY 2023 and Q4 2023 financial results
finance.yahoo.com - February 14 at 7:01 AM
Vopak reports FY 2023 and Q4 2023 financial resultsVopak reports FY 2023 and Q4 2023 financial results
globenewswire.com - February 14 at 1:00 AM
Vopak announces share buyback program to return up to EUR 300 million to shareholdersVopak announces share buyback program to return up to EUR 300 million to shareholders
globenewswire.com - February 14 at 12:58 AM
Koninklijke Vopak NV VPKKoninklijke Vopak NV VPK
morningstar.com - February 9 at 8:27 PM
Koninklijke Vopak NV (VOPA)Koninklijke Vopak NV (VOPA)
investing.com - February 7 at 3:18 AM
Organogram ministerie van DefensieOrganogram ministerie van Defensie
rijksoverheid.nl - January 22 at 12:31 AM
Koninklijke Vopak N.V. (AMS:VPK) Stocks Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?Koninklijke Vopak N.V. (AMS:VPK) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
finance.yahoo.com - January 7 at 9:51 AM
Frits Eulderink to step down as member of the Executive Board as per 24 April 2024Frits Eulderink to step down as member of the Executive Board as per 24 April 2024
finance.yahoo.com - December 19 at 1:17 AM
Private equity firms account for 48% of Koninklijke Vopak N.V.s (AMS:VPK) ownership, while individual investors account for 27%Private equity firms account for 48% of Koninklijke Vopak N.V.'s (AMS:VPK) ownership, while individual investors account for 27%
finance.yahoo.com - December 10 at 8:47 AM
Vopak portfolio updateVopak portfolio update
finance.yahoo.com - December 1 at 1:44 AM
HI, Vopak Ink Agreement to Develop Ammonia TerminalsHI, Vopak Ink Agreement to Develop Ammonia Terminals
marinelink.com - November 21 at 2:11 PM
Koninklijke Vopak (AMS:VPK) investors are sitting on a loss of 23% if they invested three years agoKoninklijke Vopak (AMS:VPK) investors are sitting on a loss of 23% if they invested three years ago
finance.yahoo.com - November 20 at 3:59 AM
Koninklijke Vopak NV VPK5Koninklijke Vopak NV VPK5
morningstar.com - November 11 at 5:39 PM
Koninklijke Vopak N.V.s (AMS:VPK) Intrinsic Value Is Potentially 66% Above Its Share PriceKoninklijke Vopak N.V.'s (AMS:VPK) Intrinsic Value Is Potentially 66% Above Its Share Price
finance.yahoo.com - November 1 at 7:55 AM
Analyst & Investor DayAnalyst & Investor Day
finance.yahoo.com - November 1 at 7:55 AM
Vopak reports on Q3 2023 resultsVopak reports on Q3 2023 results
finance.yahoo.com - October 25 at 8:12 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bank of East Asia logo

Bank of East Asia

OTCMKTS:BKEAY
The Bank of East Asia, Limited, together with its subsidiaries, provides various banking and related financial services. Its personal banking services include corporate, individual, savings, current, time deposit, and supreme accounts; and time deposits, foreign currency deposits, MAS services, and auto-payroll products, as well as safe deposit boxes and remittance services. The company also provides corporate banking services, such as SME loans and financing guarantee schemes; corporate and commercial financing products, including syndicated and construction loans, acquisition and structured financing, working capital financing, share financing and IPO-related loans, and commercial mortgages; trade finance services and expert trade solutions; factoring services; import and export trade finance; guarantee services; eTradeConnect that allows buyers and sellers to connect, transact, share information, and submit applications for financing through a single platform; cash management services; corporate wealth management products; foreign exchange and treasury products; and marine cargo, property, trade credit, employee compensation, life, savings, and endowment insurance plans. In addition, it offers private banking services comprising investment advisory services; investment solutions, such as unit trusts, linked deposits, currency trading and management, global equities and bonds investments, structured products, and options and derivatives; portfolio management services; securities and futures broking services; cyber banking, credit cards, and ATM; and various international services. The company operates outlets in Hong Kong, rest of Greater China, Singapore, Malaysia, the United Kingdom, and the United States. The Bank of East Asia, Limited was incorporated in 1918 and is headquartered in Central, Hong Kong.
Hikma Pharmaceuticals logo

Hikma Pharmaceuticals

OTCMKTS:HKMPF
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Orion Oyj logo

Orion Oyj

OTCMKTS:ORINY
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. Further, the company has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.
ROHM logo

ROHM

OTCMKTS:ROHCY
ROHM Co., Ltd. manufactures and sells electronic components worldwide. The company operates through three segments: LSI, Semiconductor Devices, and Modules. It provides ICs comprising memory, amplifiers and linear, power management, motor/actuator drivers, resistors, clocks and timers, switches and multiplexers, logic, data converters, sensors and MEMS, display drivers, interfaces, wireless LSIs, audio and video products, speech synthesis LSI, and microcontrollers. The company also offers discrete semiconductor products, such as MOSFETs, bipolar transistors, and diodes; power devices, including power transistors and diodes, SiC power devices, IGBT, and IPM; modules, including optical modules, wireless communication modules, wireless charger modules, and print heads; and opto devices comprising LEDs, LED displays, laser diodes, and optical sensors, as well as foundry services, including thin-film piezoelectric MEMS, wafers, and WL-CSP. Its products are used in industry, automotive, consumer electronics, and telecommunications applications. The company was incorporated in 1940 and is headquartered in Kyoto, Japan.
Koninklijke Vopak logo

Koninklijke Vopak

OTCMKTS:VOPKY
Koninklijke Vopak N.V., an independent tank storage company, stores and handles liquid chemicals, gases, and oil products to the energy and manufacturing markets worldwide. The company operates LPG and chemical gas, industrial, chemical, and oil terminals; and owns and operates specialized facilities consisting of tanks, jetties, truck loading stations, and pipelines. It stores and handles chemicals, such as methanol, xylenes, styrene, alpha olefins, and mono-ethylene glycol; gas, including LNG, LPG, ethylene, butadiene, and ammonia; oil products consisting of crude oil, fuel oil, diesel, jet fuel, gasoline, and naphtha; and vegoils and biofuels comprising ethanol, biodiesel, and sustainable aviation fuel. In addition, the company is involved in the development of infrastructure solutions within ports for low-carbon and renewable hydrogen, CO2, long-duration energy storage, and sustainable fuels and feedstocks. Further, it operates 76 terminals in 23 countries with a storage capacity of 35.2 million cubic meters. It serves producers, manufacturers, distributors, governments, traders, and chemical and energy companies. The company was founded in 1616 and is headquartered in Rotterdam, the Netherlands.